Healthcare provider profile · identity verified

Andrew P Schulz, MD

Family Practice · BEAVERCREEK, OH · NPI 1952365686

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	547	150
Rosuvastatin Calcium	Rosuvastatin Calcium	335	90
Levothyroxine Sodium	Levothyroxine Sodium	268	65
Losartan Potassium	Losartan Potassium	248	70
Omeprazole	Omeprazole	183	51
Lisinopril	Lisinopril	159	44
Gabapentin	Gabapentin	152	45
Metoprolol Succinate	Metoprolol Succinate	152	42
Amlodipine Besylate	Amlodipine Besylate	150	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	149	20
Ozempic	Semaglutide	142	29
Metformin Hcl	Metformin Hcl	126	37
Metformin Hcl Er	Metformin Hcl	124	42
Pantoprazole Sodium	Pantoprazole Sodium	112	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	105	26
Trazodone Hcl	Trazodone Hcl	105	26
Bupropion Xl	Bupropion Hcl	100	18
Escitalopram Oxalate	Escitalopram Oxalate	99	21
Tamsulosin Hcl	Tamsulosin Hcl	99	30
Ezetimibe	Ezetimibe	98	27
Montelukast Sodium	Montelukast Sodium	97	28
Jardiance	Empagliflozin	94	22
Furosemide	Furosemide	86	30
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	84	suppressed
Carvedilol	Carvedilol	78	24
Hydrochlorothiazide	Hydrochlorothiazide	73	21
Metoprolol Tartrate	Metoprolol Tartrate	73	16
Alendronate Sodium	Alendronate Sodium	65	17
Tizanidine Hcl	Tizanidine Hcl	63	15
Pravastatin Sodium	Pravastatin Sodium	62	18
Famotidine	Famotidine	61	18
Azithromycin	Azithromycin	57	47
Fluticasone Propionate	Fluticasone Propionate	56	22
Duloxetine Hcl	Duloxetine Hcl	55	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	15
Eliquis	Apixaban	52	15
Synthroid	Levothyroxine Sodium	52	14
Mounjaro	Tirzepatide	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	49	12
Donepezil Hcl	Donepezil Hcl	49	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	11
Lorazepam	Lorazepam	46	suppressed
Finasteride	Finasteride	43	13
Simvastatin	Simvastatin	43	13
Tramadol Hcl	Tramadol Hcl	43	16
Methocarbamol	Methocarbamol	42	25
Albuterol Sulfate Hfa	Albuterol Sulfate	41	24
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	37
Cefuroxime	Cefuroxime Axetil	39	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Meloxicam	Meloxicam	38	11
Spironolactone	Spironolactone	38	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	11
Allopurinol	Allopurinol	36	12
Memantine Hcl	Memantine Hcl	35	suppressed
Trulicity	Dulaglutide	35	11
Telmisartan	Telmisartan	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	26
Prednisone	Prednisone	32	23
Warfarin Sodium	Warfarin Sodium	31	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Amoxicillin	Amoxicillin	27	23
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Methylprednisolone	Methylprednisolone	24	22
Mirtazapine	Mirtazapine	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Primidone	Primidone	23	suppressed
Ibandronate Sodium	Ibandronate Sodium	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	11
Clonidine Hcl	Clonidine Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Estradiol	Estradiol	19	suppressed
Glipizide	Glipizide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	17	suppressed
Ondansetron Odt	Ondansetron	17	13
Potassium Chloride	Potassium Chloride	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Topiramate	Topiramate	15	suppressed
Meclizine Hcl	Meclizine Hcl	14	12
Propranolol Hcl	Propranolol Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Clonidine	Clonidine	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nadolol	Nadolol	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Baclofen	Baclofen	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error